Our results support a model by which ApoE compensates for the loss of ApoB function through transcriptional activation and post-translational modifications and provide new insights into how hepatic lipid content is regulated by ApoE, whose abnormalities are implicated in metabolic diseases. This evidence concerns the gene APOB and metabolic disease.